Ranking Profile - Larimar Therapeutics Inc

Introduction

Larimar Therapeutics Inc (Larimar Therapeutics), formerly Zafgen Inc, is a biotechnology company that discovers and develops treatments for rare diseases. It is investigating its lead product candidate CTI-1601 to treat Friedreich’s ataxia, a rare and progressive genetic disease that affects the functioning of multiple organs and systems. The company utilizes its proprietary protein replacement therapy platform to deliver missing proteins into the machinery of cells and treat rare diseases. It works in partnership with Friedreich’s Ataxia Research Alliance, Wake Forest Innovations, and The Indiana University Innovation and Commercialization Office. Larimar Therapeutics is headquartered in Bala Cynwyd, Pennsylvania, the US.